Literature DB >> 17036035

Neonatal illicit drug screening practices in Iowa: the impact of utilization of a structured screening protocol.

R Oral1, T Strang.   

Abstract

OBJECTIVE: The purpose of the study was to determine the neonatal illicit drug screening practices of Iowa birthing hospitals. STUDY
DESIGN: Cross-sectional survey design was implemented. The impact of structured screening protocols on the numbers of neonates screened and positive testing in 2004 was reviewed.
RESULTS: Of 81 birthing hospitals, 53 (65%) participated in the study. Screening and positive test rates were higher in hospitals utilizing a structured screening protocol compared to those not utilizing one (10.9 versus 2.1% and 0.9 versus 0.2%, respectively, P < 0.0001). Hospitals with higher population, numbers of outpatients, inpatients, deliveries, and availability of drug abuse treatment services utilized a structured screening protocol more often.
CONCLUSION: Utilization of a structured screening protocol increases the number of neonates screened for illicit drugs and positive testing rate regardless of urbanization. Regional standardization of structured screening protocols may improve the recognition of perinatal illicit drug exposure and provision of treatment services.

Mesh:

Substances:

Year:  2006        PMID: 17036035     DOI: 10.1038/sj.jp.7211601

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  6 in total

1.  Nonmedical Use of Prescription Opioids among Pregnant U.S. Women.

Authors:  Katy B Kozhimannil; Amy J Graves; Robert Levy; Stephen W Patrick
Journal:  Womens Health Issues       Date:  2017-04-11

2.  Does adopting a prenatal substance use protocol reduce racial disparities in CPS reporting related to maternal drug use? A California case study.

Authors:  S C M Roberts; E Zahnd; C Sufrin; M A Armstrong
Journal:  J Perinatol       Date:  2014-09-18       Impact factor: 2.521

3.  Drug testing for newborn exposure to illicit substances in pregnancy: pitfalls and pearls.

Authors:  Karen J Farst; Jimmie L Valentine; R Whit Hall
Journal:  Int J Pediatr       Date:  2011-07-17

Review 4.  Universal alcohol/drug screening in prenatal care: a strategy for reducing racial disparities? Questioning the assumptions.

Authors:  Sarah C M Roberts; Amani Nuru-Jeter
Journal:  Matern Child Health J       Date:  2011-11

Review 5.  Applicability of non-invasively collected matrices for human biomonitoring.

Authors:  Roel Smolders; Karl-Werner Schramm; Marc Nickmilder; Greet Schoeters
Journal:  Environ Health       Date:  2009-03-09       Impact factor: 5.984

6.  Retrospective analysis of the diagnostic yield of newborn drug testing.

Authors:  Kelly E Wood; Lori L Sinclair; Carolyn D Rysgaard; Frederick G Strathmann; Gwendolyn A McMillin; Matthew D Krasowski
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-29       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.